Bespoke biologics,
made in West Africa.
Recombinant proteins, vaccine antigens and accredited testing for manufacturers and research institutions across Africa. Priced in your currency, paid the way you already pay.
Prices in
- Structural Genetics design report5 daysGH₵ 27,360
- Custom recombinant protein, 10 mg5 weeksGH₵ 48,640
- ISO/IEC 17025 course, one seat3 days in AccraGH₵ 9,424
MTN MoMo, Telecel Cash, AT Money, card, stablecoin or invoice. Illustrative prices and indicative rates until Afrivax publishes its rate cards.
Four ways to work with us
Published rate cards on all four. No contact wall below programme scale.
Bespoke production
Recombinant proteins, vaccine antigens, epitope-display nanoparticles and diagnostic antigens, designed with you and made in eggs.
from GH₵ 48,640protein, 10 mg
Design and price online
Quality control and testing
Sterility, microbial limits, endotoxin, HPLC, GC and UV analytics, method development and batch release.
from GH₵ 3,648sterility test
Book a test
Training and consulting
ISO 9001, 17025 and 15189, GMP and GxP readiness, QMS consulting and lab safety, taught in Accra.
from GH₵ 9,424ISO 17025 seat
See the course calendar
Manufacturing and transfer
GLP and GMP clinical production, scale-up on the egg platform, technology transfer and EggPharm facilities.
from GH₵ 212,800operator training
Talk to the network
Reagents for the outbreaks happening now
Antigens, controls and diagnostic components for mpox and filovirus work, in stock or made to order, shipped within the region.
- Active programmeMpox (MPXV)Clade II circulating in West AfricaEpitope-display nanoparticle antigens in development on the AdCEV platform
- Response catalogueEbola, BundibugyoDeclared a public health emergency; no approved vaccine for this speciesFilovirus GP antigens and diagnostic controls
- CatalogueLassa feverEndemic, seasonal across West AfricaDiagnostic antigens and assay controls
Outbreak statuses and strain names are re-verified against WHO and Africa CDC before publication and kept current. Items not yet produced in Afrivax's own hands are marked in development.
Built for two customers
The small manufacturer
A pharmaceutical or diagnostics manufacturer in Ghana, Nigeria or the wider region who needs a custom antigen, a validated method or an accredited result, without a six-month procurement cycle or an import licence.
What you get: published rate cards, local-currency pricing, mobile-money payment, a named analyst, and a result you can put in a regulatory file.
The academic researcher
A university or institute scientist with grant funding who today waits months and pays in hard currency to import a protein that could be made 20 km away.
What you get: a quotation PDF for the bursar in the morning, a price in cedis, and a construct designed with you rather than for you.
Eggs as miniature factories
The AdCEV expression system turns fertilised eggs into single-use bioreactors. The starting material is DNA, not a frozen cell bank, so a run begins in days, scales linearly, and needs infrastructure that already exists across West Africa.
How the network works- Local
- Vaccine-quality eggs sourced in the region
- Linear
- One egg or a million, the same process
- Low capital
- Power and water, not stainless steel
- Safe
- Recombinant, no pathogenic organisms
Pandemithon
Preparedness is real when capability is practised.
A vaccine development programme run as linked, hands-on campaigns. Teams move from regional outbreak evidence to design, egg production, testing and a decision on a candidate, and the country keeps the people, the methods and the evidence. The 2026 campaign is the Mpox vaccine project.
Start with one construct.
Design and price it in minutes. Pay in cedis, naira, shillings, dollars or stablecoin.